Home » Topics » BioWorld Science

BioWorld Science
RSS

Once-daily dermal administration of Epoladerm well tolerated in four preclinical studies

Jan. 19, 2022

Sodium salt of a quinoline derivative shows anticancer efficacy in vivo

Jan. 19, 2022

Yes targeting useful for treatment of HCC, researchers suggest

Jan. 19, 2022

Ortho-hIL-2/ortho-hIL-2Rbeta pair enhances antitumor efficacy of engineered T cells

Jan. 19, 2022

New kappa-opioid receptor agonists identified at Humanwell Pharmaceutical US

Jan. 19, 2022

Charite-Universitaetsmedizin Berlin, Sapreme Technologies present new saponin derivatives

Jan. 19, 2022

Idorsia Pharmaceuticals discovers Kv7 potassium channel activators

Jan. 19, 2022

ATR kinase blockade useful for treating pancreatic ductal adenocarcinoma

Jan. 19, 2022

MAO mutant zebrafish exhibit abnormal brain development

Jan. 19, 2022

SUW-133 diminishes HIV viral load in vivo

Jan. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...